Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Psychometric Validation of the Patient-Reported Experience Measure (PREM) Questionnaire "HowRwe" in Patients With Respiratory Disease Receiving Home Respiratory Therapies.
Rudilla D, Alonso T, García E, Pérez P, Valenzuela C, Girón R, Zamora E, Soriano J, Landete P, Ancochea J. Rudilla D, et al. Among authors: alonso t. Open Respir Arch. 2024 Feb 15;6(2):100304. doi: 10.1016/j.opresp.2024.100304. eCollection 2024 Apr-Jun. Open Respir Arch. 2024. PMID: 38496265 Free PMC article.
Psychological Profile of Patients Diagnosed With Idiopathic Pulmonary Fibrosis.
Rudilla D, Beceiro MJ, Alonso T, Oliver A, Soriano J, Valenzuela C, Ancochea J. Rudilla D, et al. Among authors: alonso t. Arch Bronconeumol. 2022 Feb;58(2):191-193. doi: 10.1016/j.arbres.2021.04.025. Epub 2021 May 5. Arch Bronconeumol. 2022. PMID: 34045108 English, Spanish. No abstract available.
SARS-CoV-2 Viremia Precedes an IL6 Response in Severe COVID-19 Patients: Results of a Longitudinal Prospective Cohort.
Roy-Vallejo E, Cardeñoso L, Triguero-Martínez A, Chicot Llano M, Zurita N, Ávalos E, Barrios A, Hernando J, Ortiz J, Rodríguez-García SC, Ciudad Sañudo M, Marcos C, García Castillo E, Fontán García-Rodrigo L, González B, Méndez R, Iturrate I, Sanz-García A, Villa A, Sánchez-Azofra A, Quicios B, Arribas D, Álvarez Rodríguez J, Patiño P, Trigueros M, Uriarte M, Martín-Ramírez A, Arévalo Román C, Galván-Román JM, García-Vicuña R, Ancochea J, Muñoz-Calleja C, Fernández-Ruiz E, de la Cámara R, Suárez Fernández C, González-Álvaro I, Rodríguez-Serrano DA; PREDINMUN-COVID Group. Roy-Vallejo E, et al. Front Med (Lausanne). 2022 Jun 15;9:855639. doi: 10.3389/fmed.2022.855639. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35783606 Free PMC article.
Respiratory acidosis secondary to drug therapy.
Alonso T, García E, Segrelles G, Zamora E. Alonso T, et al. Arch Bronconeumol. 2015 Apr;51(4):204-5. doi: 10.1016/j.arbres.2014.04.006. Epub 2014 Oct 30. Arch Bronconeumol. 2015. PMID: 25443584 English, Spanish. No abstract available.
Tobramycin inhalation powder (TOBI Podhaler) for the treatment of lung infection in patients with cystic fibrosis.
Vazquez-Espinosa E, Marcos C, Alonso T, Giron RM, Gomez-Punter RM, Garcia-Castillo E, Zamora E, Cisneros C, Garcia J, Valenzuela C, Ancochea J. Vazquez-Espinosa E, et al. Among authors: alonso t. Expert Rev Anti Infect Ther. 2016;14(1):9-17. doi: 10.1586/14787210.2016.1118344. Epub 2015 Dec 4. Expert Rev Anti Infect Ther. 2016. PMID: 26559549 Review.
Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.
Rodríguez-Serrano DA, Roy-Vallejo E, Zurita Cruz ND, Martín Ramírez A, Rodríguez-García SC, Arevalillo-Fernández N, Galván-Román JM, Fontán García-Rodrigo L, Vega-Piris L, Chicot Llano M, Arribas Méndez D, González de Marcos B, Hernando Santos J, Sánchez Azofra A, Ávalos Pérez-Urria E, Rodriguez-Cortes P, Esparcia L, Marcos-Jimenez A, Sánchez-Alonso S, Llorente I, Soriano J, Suárez Fernández C, García-Vicuña R, Ancochea J, Sanz J, Muñoz-Calleja C, de la Cámara R, Canabal Berlanga A, González-Álvaro I, Cardeñoso L; REINMUN-COVID Group. Rodríguez-Serrano DA, et al. Sci Rep. 2021 Jun 23;11(1):13134. doi: 10.1038/s41598-021-92497-1. Sci Rep. 2021. PMID: 34162948 Free PMC article.
IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study.
Galván-Román JM, Rodríguez-García SC, Roy-Vallejo E, Marcos-Jiménez A, Sánchez-Alonso S, Fernández-Díaz C, Alcaraz-Serna A, Mateu-Albero T, Rodríguez-Cortes P, Sánchez-Cerrillo I, Esparcia L, Martínez-Fleta P, López-Sanz C, Gabrie L, Del Campo Guerola L, Suárez-Fernández C, Ancochea J, Canabal A, Albert P, Rodríguez-Serrano DA, Aguilar JM, Del Arco C, de Los Santos I, García-Fraile L, de la Cámara R, Serra JM, Ramírez E, Alonso T, Landete P, Soriano JB, Martín-Gayo E, Fraile Torres A, Zurita Cruz ND, García-Vicuña R, Cardeñoso L, Sánchez-Madrid F, Alfranca A, Muñoz-Calleja C, González-Álvaro I; REINMUN-COVID Group. Galván-Román JM, et al. Among authors: alonso t. J Allergy Clin Immunol. 2021 Jan;147(1):72-80.e8. doi: 10.1016/j.jaci.2020.09.018. Epub 2020 Sep 30. J Allergy Clin Immunol. 2021. PMID: 33010257 Free PMC article. Clinical Trial.
155 results